Clinical characteristics of adverse events associated with therapeutic monoclonal antibodies in Korea.
Da Woon SimKyung Hee ParkHye Jung ParkYoung Woong SonSang Chul LeeJung-Won ParkJae-Hyun LeePublished in: Pharmacoepidemiology and drug safety (2016)
Hypersensitivity reactions were observed more frequently than expected, although no previously unrecognized reactions were observed. Adverse reactions occurred more frequently in children and in elderly patients. Close monitoring of adverse reactions to therapeutic mAbs is therefore warranted because these can potentially cause serious medical conditions or death. Copyright © 2016 John Wiley & Sons, Ltd.